ArticleSensors (Basel, Switzerland)2026
Self-Explaining Neural Networks for Transparent Parkinson's Disease Screening.
Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Transparent clinical decision-making remains a critical barrier to deploying deep learning in medical diagnosis. Post hoc explanation methods approximate model behaviour after training but cannot guarantee that explanations faithfully reflect the underlying reasoning. This study proposes a Self-Explaining Neural Network (SENN) for Parkinson's Disease (PD) screening via Ground Reaction Force (GRF) gait analysis, enforcing intrinsic interpretability through learnable basis concepts and input-dependent relevance scores computed jointly with the prediction. The architecture combines a four-block residual CNN backbone with stochastic depth regularisation, a 16-concept encoder with diversity and stability constraints, and temperature-scaled probability calibration for reliable clinical operating points. Evaluated on the PhysioNet Gait in Parkinson's Disease dataset (306 subjects, 16 GRF sensors per foot), SENN achieves a subject-level ROC-AUC of 0.916 [95% CI: 0.867-0.964], sensitivity of 0.913 [0.862-0.963], specificity of 0.671 [0.485-0.858], and Average Precision of 0.942 [0.918-0.967], reported across five independent random seeds. Comparative evaluation against four deep learning baselines-CNN-Residual, BiLSTM, CNN-LSTM, and CNN-Attention-confirms that the interpretability constraints impose no statistically significant reduction in discriminative performance, with all pairwise ROC-AUC confidence intervals overlapping. Concept-level analysis reveals that the three most discriminative concepts correspond to disrupted midfoot loading patterns, increased step-length variability, and bilateral cadence asymmetry-all established biomechanical hallmarks of parkinsonian gait-providing clinically grounded, patient-specific explanations without post hoc approximation. These findings demonstrate that rigorous intrinsic interpretability and competitive predictive accuracy are simultaneously achievable in deep gait analysis, supporting the clinical adoption of transparent diagnostic AI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.